Hester Biosciences approves raising up to Rs 150cr via QIP, preferential allotment The board also approved reappointment of Rajiv Gandhi, CEO and Managing Director of the company, for a period of three years from April 1, 2020 to March 31, 2023, subject to approval of members through postal ballot process.
Feedback
HESTERBIO 
Reputation: 2,149 • Dec 18, 2019 7:17 PM
Vote
Comment
Share